R

Redhill Biopharma Ltd
D

RDHL

2.07000
USD
-0.09
(-4.17%)
مغلق
حجم التداول
774
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
3,662,078
أصول ذات صلة
A
AKRO
-0.370
(-0.82%)
44.910 USD
A
ALLO
0.02000
(1.19%)
1.70500 USD
D
DRRX
-0.03990
(-6.44%)
0.58010 USD
G
GNFT
0.49000
(13.76%)
4.05000 USD
I
IMUX
-0.03000
(-2.56%)
1.14000 USD
K
KALA
-0.03000
(-0.79%)
3.79000 USD
R
RCKT
0.16000
(2.04%)
8.02000 USD
S
SNGX
0.00000
(0.00%)
1.92000 USD
المزيد
الأخبار المقالات

العنوان: Redhill Biopharma Ltd

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-relatedproducts in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.